share_log

康泰生物(300601.SZ):部分产品的开发涉及合成生物相关技术平台

Shenzhen Kangtai Biological Products (300601.SZ) has developed some products using synthetic biology-related technology platforms.

Gelonghui Finance ·  Jun 7 05:52

Kangtai Biological (300601.SZ) stated on the investor interaction platform on June 7th that the development of some of the company's products involves synthetic biology-related technology platforms, such as recombinant hepatitis B vaccines; and the development of new synthetic biology products such as respiratory syncytial virus (RSV) vaccines, herpes zoster vaccines, etc. is being pushed forward as planned.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment